These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

331 related items for PubMed ID: 36240247

  • 21. [TORCH infections in mothers as a cause of neonatal morbidity].
    Mladina N, Mehikić G, Pasić A.
    Med Arh; 2000; 54(5-6):273-6. PubMed ID: 11219902
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Simultaneous Seroprevalence to Toxoplasma gondii, Cytomegalovirus and Rubella Virus in Childbearing Women from Western Romania.
    Mocanu AG, Gorun F, Ciohat I, Navolan D, Malita D, Vilibic-Cavlek T, Dahma G, Neamtu R, Popescu D, Cioca A, Craina M.
    Medicina (Kaunas); 2021 Sep 02; 57(9):. PubMed ID: 34577850
    [Abstract] [Full Text] [Related]

  • 24. Standardization of an in-house multiplex real-time polymerase chain reaction for the simultaneous detection of Toxoplasma gondii, Rubella virus, cytomegalovirus, herpes simplex Virus 1 and 2, and Treponema pallidum infection among pregnant women.
    Rajendiran P, Saravanan N, Ramamurthy M, Sankar S, Aruliah R, Nandagopal B, Sridharan G.
    Indian J Public Health; 2021 Sep 02; 65(4):369-374. PubMed ID: 34975080
    [Abstract] [Full Text] [Related]

  • 25. TORCH infection in women with bad obstetric history--a pilot study in Kumaon region.
    Thapliyal N, Shukla PK, Kumar B, Upadhyay S, Jain G.
    Indian J Pathol Microbiol; 2005 Oct 02; 48(4):551-3. PubMed ID: 16366124
    [Abstract] [Full Text] [Related]

  • 26. Serological status for TORCH in women of childbearing age: a decade-long surveillance (2012-2022) in Italy.
    Palazzotto E, Bonura F, Calà C, Capra G, Pistoia D, Mangione D, Mascarella C, Minì G, Enea M, Giammanco GM, Ferraro D, De Grazia S.
    J Med Microbiol; 2023 Jul 02; 72(7):. PubMed ID: 37458733
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Antenatal screening for congenital infection with rubella, cytomegalovirus and toxoplasma.
    Sfameni SF, Skurrie IJ, Gilbert GL.
    Aust N Z J Obstet Gynaecol; 1986 Nov 02; 26(4):257-60. PubMed ID: 3030255
    [Abstract] [Full Text] [Related]

  • 30. Clinical epidemiology of Epstein-Barr virus-associated Lymphoproliferative Disorders (EBV-LPDs) in hospitalized children: A six-year multi-institutional study in China.
    Dilmurat D, Wang X, Gao L, Tian J, Ai J, Zhang L, Liu M, Feng G, Zeng Y, Wang R, Xie Z.
    Ital J Pediatr; 2024 Jul 02; 50(1):125. PubMed ID: 38956696
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. TORCH Infections. Toxoplasmosis, Other (syphilis, varicella-zoster, parvovirus B19), Rubella, Cytomegalovirus (CMV), and Herpes infections.
    Stegmann BJ, Carey JC.
    Curr Womens Health Rep; 2002 Aug 02; 2(4):253-8. PubMed ID: 12150751
    [Abstract] [Full Text] [Related]

  • 34. The Term Newborn: Congenital Infections.
    Moodley A, Payton KSE.
    Clin Perinatol; 2021 Aug 02; 48(3):485-511. PubMed ID: 34353577
    [Abstract] [Full Text] [Related]

  • 35. TORCH test for fetal medicine indications: only CMV is necessary in the United Kingdom.
    Abdel-Fattah SA, Bhat A, Illanes S, Bartha JL, Carrington D.
    Prenat Diagn; 2005 Nov 02; 25(11):1028-31. PubMed ID: 16231309
    [Abstract] [Full Text] [Related]

  • 36. Seasonal influence on TORCH infection and analysis of multi-positive samples with indirect immunofluorescence assay.
    Chen L, Liu J, Shi L, Song Y, Song Y, Gao Y, Dong Y, Li L, Shen M, Zhai Y, Cao Z.
    J Clin Lab Anal; 2019 May 02; 33(4):e22828. PubMed ID: 30666721
    [Abstract] [Full Text] [Related]

  • 37. Exhaustive TORCH Pathogen Diagnostics Corroborate Zika Virus Etiology of Congenital Malformations in Northeastern Brazil.
    Moreira-Soto A, Cabral R, Pedroso C, Eschbach-Bludau M, Rockstroh A, Vargas LA, Postigo-Hidalgo I, Luz E, Sampaio GS, Drosten C, Netto EM, Jaenisch T, Ulbert S, Sarno M, Brites C, Drexler JF.
    mSphere; 2018 Aug 08; 3(4):. PubMed ID: 30089647
    [Abstract] [Full Text] [Related]

  • 38. Seroprevalence of ToRCH Pathogens among Children Admitted to a Tertiary Care Hospital in Eastern India for Cataract Surgery and Cochlear Transplantation.
    Patra A, Parija S, Parida PK, Behera SK, Ghosh A.
    Curr Pediatr Rev; 2024 Aug 08; 20(3):365-369. PubMed ID: 36809946
    [Abstract] [Full Text] [Related]

  • 39. [Analysis of serological findings and clinical manifestations of TORCH infections in newborns].
    Wang L, Li KH, Liu H, Liu JY, Li YJ.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Sep 08; 17(3):283-4. PubMed ID: 15340579
    [Abstract] [Full Text] [Related]

  • 40. TORCH syndrome and TORCH screening.
    Lancet; 1990 Jun 30; 335(8705):1559-61. PubMed ID: 1972489
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.